SMAD4 and non-small cell lung carcinoma: The results showed that the degree of cell differentiation (P < 0.001), lymph node metastasis (P < 0.001) and clinical stage of NSCLC (P = 0.007) directly affected the expression of Smad4, and the three showed a strong correlation with the expression of Smad4.